Skip to content

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy - Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029134
Enrollment
10
Registered
2017-09-14
Start date
2017-11-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

According to the diagnostic criteria for mood (affective) disorders:ICD-10

Interventions

Installing using drugs used saimapad in modified electroconvulsive therapy in the study subjects 10. The modified electroconvulsive therapy and other enforcement procedures there is no difference. (

Sponsors

Department of Pychiatry, Kitasato University East hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study participants shall meet all the following criteria. (1)Persons diagnosed with F3 mood (affective) disorders ICD-10 diagnostic criteria using (2)Persons wearing saimapad on the bilateral side head, carried a modified electroconvulsive therapy (3)Agree to the proposed person or obtained from the Novotel (spouse, brothers and sisters, his lineal relative within the relatives, guardian or curator shall)

Exclusion criteria

Exclusion criteria: Otherwise excluded from study participants. (1) if the person or from the Novotel was discontinued participation in research proposal (2) in the PreTac fluid and Gerad Z-101BA until now or further if any allergic symptoms

Design outcomes

Primary

MeasureTime frame
Static impedance (measured with 6 microampere) at placing electrodes on the patient skin and dynamic impedance (measured with 0.9 ampere) during administrating electric current to the brain.

Secondary

MeasureTime frame
Number of times spent with saimapad and Postictal Suppression Index (decrease in value immediately after the attack, completed average amplitude of 3 seconds between viewed in percent as reduced the average amplitude of the maximum amplitude of the seizure during 3 seconds, which one of the indicators of the quality of the attack)

Countries

Japan

Contacts

Public ContactTomoya Shimano

Kitasato University East hospital Department of Psychiatry

dm17013@st.kitasato-u.ac.jp042-748-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026